Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Simpson-Golabi-Behmel syndrome × codrituzumab × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Simpson-Golabi-Behmel syndrome 1 Recurrence 1 Hepatoblastoma 1

Interventions

tislelizumab 1 fludarabine 1 codrituzumab 1 Cyclophosphamide 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04928677 2026-02-17

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting

Gastrointestinal

Simpson-Golabi-Behmel syndrome, Recurrence, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡